Publications

  1. Wang L, Zeng X, Chen S, Ding L, Zhong J, Zhao JC, Wang L, Sarver A, Koller A, Zhi J, Ma Y, Yu J, Chen J, Huang H. BRCA1 is a negative modulator of the PRC2 complex. EMBO J. 2013 May 29; 32(11):1584-97. Epub 2013 Apr 26. 2319284
    View PubMed
  2. Xiao Q, Qu K, Wang C, Kong Y, Liu C, Jiang D, Saiyin H, Jia F, Ni C, Chen T, Zhang Y, Zhang P, Qin W, Sun Q, Wang H, Yi Q, Liu J, Huang H, Yu L. HDGF-related protein-3 is required for anchorage-independent survival and chemoresistance in hepatocellular carcinomas. Gut. 2013 Mar; 62(3):440-51. Epub 2012 Apr 05. 2307413
    View PubMed
  3. Yang Y, Wang C, Zhang P, Gao K, Wang D, Yu H, Zhang T, Jiang S, Hexige S, Hong Z, Yasui A, Liu JO, Huang H, Yu L. Polycomb group protein PHF1 regulates p53-dependent cell growth arrest and apoptosis. J Biol Chem. 2013 Jan 4; 288(1):529-39. Epub 2012 Nov 13. 2300506
    View PubMed
  4. Bohrer LR, Liu P, Zhong J, Pan Y, Angstman J, Brand LJ, Dehm SM, Huang H. FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants. Prostate. 2013; 73(10):1017-27. 2329806
  5. Jiang J, Pan Y, Regan KM, Wu C, Zhang X, Tindall DJ, Huang H. Androgens repress expression of the F-box protein Skp2 via p107 dependent and independent mechanisms in LNCaP prostate cancer cells. Prostate. 2012 Feb 1; 72(2):225-32. Epub 2011 May 31. 2216788
    View PubMed
  6. Mao J, Yu H, Wang C, Sun L, Jiang W, Zhang P, Xiao Q, Han D, Saiyin H, Zhu J, Chen T, Roberts LR, Huang H, Yu L. Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomas. Carcinogenesis. 2012; 33(12):2568-77. 2289187
  7. Huang H, Tindall DJ. Regulation of FOXO protein stability via ubiquitination and proteasome degradation. Biochim Biophys Acta. 2011 Nov; 1813(11):1961-4. Epub 2011 Jan 14. 2196588
    View PubMed
  8. Lu H, Liu P, Pan Y, Huang H. Inhibition of cyclin-dependent kinase phosphorylation of FOXO1 and prostate cancer cell growth by a peptide derived from FOXO1. Neoplasia. 2011 Sep; 13(9):854-63. 2203374
    View PubMed
  9. Lu H, Huang H. FOXO1: a potential target for human diseases. Curr Drug Targets. 2011 Aug; 12(9):1235-44. 2196585
    View PubMed
  10. Zhang H, Pan Y, Zheng L, Choe C, Lindgren B, Jensen ED, Westendorf JJ, Cheng L, Huang H. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. Cancer Res. 2011 May 1; 71(9):3257-67. Epub 2011 Apr 19. 2160214
    View PubMed
  11. Zeng X, Chen S, Huang H. Phosphorylation of EZH2 by CDK1 and CDK2: a possible regulatory mechanism of transmission of the H3K27me3 epigenetic mark through cell divisions. Cell Cycle. 2011 Feb 15; 10(4):579-83. 2190727
    View PubMed
  12. Chen S, Bohrer LR, Rai AN, Pan Y, Gan L, Zhou X, Bagchi A, Simon JA, Huang H. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat Cell Biol. 2010 Nov; 12(11):1108-14. Epub 2010 Oct 10. 2190729
    View PubMed
  13. Bohrer LR, Chen S, Hallstrom TC, Huang H. Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer. Endocrinology. 2010 Nov; 151(11):5136-45. Epub 2010 Sep 29. 2190731
    View PubMed
  14. Jiang J, Huang H. Targeting the Androgen Receptor by Taxol in Castration-Resistant Prostate Cancer. Mol Cell Pharmacol. 2010 Jan 1; 2(1):1-5. 2190732
    View PubMed
  15. Wang D, Montgomery RB, Schmidt LJ, Mostaghel EA, Huang H, Nelson PS, Tindall DJ. Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression. Cancer Res. 2009 Dec 15; 69(24):9448-56. 1974100
    View PubMed
  16. Gan L, Chen S, Wang Y, Watahiki A, Bohrer L, Sun Z, Wang YZ, Huang H. Inhibition of the androgen receptor as a novel mechanism of Taxol chemotherapy in prostate cancer. Cancer Res. 2009; 69:8386-8394. 2190734
  17. Gan L, Liu P, Lu H, Chen H, Yang J, McCarthy JB, Knudsen KE, Huang H. Cyclin D1 promotes anchorage-independent cell survival by inhibiting FOXO-mediated anoikis. Cell Death Differ. 2009; 16:1408-17. 2190735
  18. Liu P, Li S, Gan L, Kao TP, Huang H. A transcription-independent function of FOXO1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells. Cancer Res. 2008. 2190736
  19. Liu P, Kao TP, Huang H. CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor. Oncogene. 2008; 27:4733-44. 2190737
  20. Huang H, Tindall DJ. Dynamic FoxO transcription factors. J Cell Sci. 2007 Aug 1; 120(Pt 15):2479-87. 1836950
    View PubMed
  21. Huang H, Tindall DJ. CDK2 and FOXO1: a fork in the road for cell fate decisions. Cell Cycle. 2007 Apr 15; 6(8):902-6. Epub 2007 Apr 05. 1820545
    View PubMed
  22. Huang H, Regan KM, Lou Z, Chen J, Tindall DJ. CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science. 2006 Oct 13; 314(5797):294-7. 1786729
    View PubMed
  23. Huang H, Tindall DJ. FOXO factors: a matter of life and death. Future Oncol. 2006 Feb; 2(1):83-9. 1782510
    View PubMed
  24. Huang H, Regan KM, Wang F, Wang D, Smith DI, van Deursen JM, Tindall DJ. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci U S A. 2005 Feb 1; 102(5):1649-54. Epub 2005 Jan 24. 1694132
    View PubMed
  25. Huang H, Muddiman DC, Tindall DJ. Androgens negatively regulate forkhead transcription factor FKHR (FOXO1) through a proteolytic mechanism in prostate cancer cells. J Biol Chem. 2004 Apr 2; 279(14):13866-77. Epub 2004 Jan 15. 1641292
    View PubMed
  26. Huang H, Zegarra-Moro OL, Benson D, Tindall DJ. Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells. Oncogene. 2004 Mar 18; 23(12):2161-76. 1639595
    View PubMed
  27. Santos AF, Huang H, Tindall DJ. The androgen receptor and its clinical relevance in prostate cancer. Steroid. 2004; 69:79-85. 2191662
  28. Deocampo ND, Huang H, Tindall DJ. The role of PTEN in the progression and survival of prostate cancer. Minerva Endocrinol. 2003 Jun; 28(2):145-53. 1644107
    View PubMed
  29. Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ. Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res. 2002 Feb 15; 62(4):1008-13. 1008274
    View PubMed
  30. Debes JD, Schmidt LJ, Huang H, Tindall DJ. p300 mediates interleukin-6-dependent transactivation of the androgen receptor. Cancer Research. 2002; 62:5632-5636. 2196590
  31. Huang H, Tindall DJ. The role of the androgen receptor in prostate cancer. Crit Rev Eukaryot Gene Expr. 2002; 12(3):193-207. 1416802
    View PubMed
  32. Grossmann ME, Huang H, Tindall DJ. Androgen receptor signaling in androgen-refractory prostate cancer. J Natl Cancer Inst. 2001 Nov 21; 93(22):1687-97. 1006934
    View PubMed
  33. Murillo H, Huang H, Schmidt LJ, Smith DI, Tindall DJ. Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state. Endocrinology. 2001 Nov; 142(11):4795-805. 1006633
    View PubMed
  34. Huang H, Cheville JC, Pan Y, Roche PC, Schmidt LJ, Tindall DJ. PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression. J Biol Chem. 2001 Oct 19; 276(42):38830-6. Epub 2001 Aug 08. 1006394
    View PubMed
  35. Shridhar V, Bible KC, Staub J, Avula R, Lee YK, Kalli K, Huang H, Hartmann LC, Kaufmann SH, Smith DI. Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer. Cancer Res. 2001 May 15; 61(10):4258-65. 1004958
    View PubMed
  36. Zhang JS, Wang L, Huang H, Nelson M, Smith DI. Keratin 23 (K23), a novel acidic keratin, is highly induced by histone deacetylase inhibitors during differentiation of pancreatic cancer cells. Genes Chromosomes Cancer. 2001 Feb; 30(2):123-35. 1977557
    View PubMed
  37. Huang H, Reed CP, Zhang JS, Shridhar V, Wang L, Smith DI. Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells. Cancer Res. 1999 Jun 15; 59(12):2981-8. 1010730
    View PubMed
  38. Wang L, Darling J, Zhang JS, Huang H, Liu W, Smith DI. Allele-specific late replication and fragility of the most active common fragile site, FRA3B. Hum Mol Genet. 1999 Mar; 8(3):431-7. 1009697
    View PubMed
  39. Huang H, Reed CP, Mordi A, Lomberk G, Wang L, Shridhar V, Hartmann L, Jenkins R, Smith DI. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer. Genes Chromosomes Cancer. 1999 Jan; 24(1):48-55. 1009195
    View PubMed
  40. Shi Q, Shan X, Zhang J, Zhang X, Chen Y, Huang H, Yu L, Zhao S, Zheng Q, Adler ID. A DNA probe suitable for the detection of chromosome 21 copy number in human interphase nuclei by fluorescence in situ hybridization. Chinese Journal of Medical Genetics. 1999; 16:36-40. 2191674
  41. Huang H, Qian J, Proffit J, Wilber K, Jenkins R, Smith DI. FRA7G extends over a broad region: coincidence of human endogenous retroviral sequences (HERV-H) and small polydispersed circular DNAs (spcDNA) and fragile sites. Oncogene. 1998 May 7; 16(18):2311-9. 1019425
    View PubMed
  42. Jenkins RB, Qian J, Lee HK, Huang H, Hirasawa K, Bostwick DG, Proffitt J, Wilber K, Lieber MM, Liu W, Smith DI. A molecular cytogenetic analysis of 7q31 in prostate cancer. Cancer Res. 1998 Feb 15; 58(4):759-66. 1018996
    View PubMed
  43. Huang H, Qian C, Jenkins RB, Smith DI. Fish mapping of YAC clones at human chromosomal band 7q31.2: identification of YACS spanning FRA7G within the common region of LOH in breast and prostate cancer. Genes Chromosomes Cancer. 1998 Feb; 21(2):152-9. 1018878
    View PubMed
  44. Smith DI, Huang H, Wang L. Common fragile sites and cancer (review). Int J Oncol. 1998 Jan; 12(1):187-96. 1020931
    View PubMed
  45. Huang H, Zhang X, Chen Y. Chromosomal homologies between Hom sapiens and Macaca mulatta and implications for human chromosome evolution. Acta Zoologica Sinica. 1998; 50:187-196. 2191676
  46. Mai M, Huang H, Reed CP, Qian C, Smith JS, Alderete B, Jenkins RB, Smith DI, Liu W. Genomic organization of p73 and mutation analysis of this gene in oligodendrogliomas with chromosome 1p deletions. Genomics. 1998; 51:359-63. 2191663
  47. Shi Q, Zhang J, Pan S, Zhang X, Chen Y, San X, Huang H, Yu L, Zhao S, Zhang Q, Adler ID. Studies of meiotic origin of the extra chromosome 21 in Down syndromes detected by using (GT) in polymorphic DNA markers. Acta Genetica Sinica. 1998; 25:478-484. 2191671
  48. Pan Y, Xue Y, Huang H, Chen Y, Xia X, Guo Y, Xie X, Ran C. The application of chromosome painting technique to study hematological malignancies. Chinese Journal of Medical Genetics. 1997; 14:203-206. 2191678
  49. Pan S, Zhang X, Huang H, Chen Y, Huang G. Study of human, Macaca mulatta, Macaca fasicularis chromosome using fluorescence in situ hybridization (FISH). Hereditas. 1997; 19:9-12. 2191679
  50. Han S, Yu L, Huang H, Xu L, Li X, Zhao S. A new method of isolating YAC DNA used as probe for FISH. High Technology Letters. 1996; 6:38-41. 2191681
  51. Zhang X, Huang H, Chen Y, Pan Y, Xue Y, Guo Y, Xie X, Ran C. Detection of rare ph translocation in chronic myelogenous leukemia by chromosome painting. Chinese Journal of Medical Genetics. 1996; 13:337-340. 2191683
  52. Huang H, Zhang X, Chen Y, Cui Y. A study on complicated chromosome translocation by fluorescence in situ hybridization (FISH) of G-banded chromosomes. Acta Genetica Sinica. 1996; 23:338-342. 2191684
  53. Huang H, Zhang X, Xue M, Chen Y, Xu Z, Wang X. A de novo chromosome aberration in uterine leiomyomas detected by fluorescence in situ hybridization. Chinese Journal of Medical Genetics. 1995; 12:237-238. 2191686
  54. Huang H, Zhang X, Chen Y. Studies of the homology of chromosomes between human being and rhesus monkey with chromosomal in situ suppression hybridization. Acta Genetica Sinica. 1993; 20:193-200. 2191688
  55. Huang H, Chen Y. Nonradioactive chromosomal in situ hybridization and its applications. Foreign Medicine. 1993; 16:70-75. 2191690